Your browser doesn't support javascript.
loading
Modelling the concentration of anti-SARS-CoV-2 immunoglobulin G in intravenous immunoglobulin product batches.
Stinca, Sara; Barnes, Thomas W; Vogel, Peter; Meyers, Wilfried; Schulte-Pelkum, Johannes; Filchtinski, Daniel; Steller, Laura; Hauser, Thomas; Manni, Sandro; Gardiner, David F; Popik, Sharon; Roth, Nathan J; Schuetz, Patrick.
Afiliación
  • Stinca S; Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland.
  • Barnes TW; Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland.
  • Vogel P; Global Digital Core, Plasma Product Development, Research & Development, CSL Behring Innovation GmbH, Marburg, Germany.
  • Meyers W; Global Digital Core, Plasma Product Development, Research & Development, CSL Behring Innovation GmbH, Marburg, Germany.
  • Schulte-Pelkum J; Assay Design, Thermo Fisher Scientific ImmunoDiagnostics Phadia GmbH, Freiburg, Germany.
  • Filchtinski D; Assay Design, Thermo Fisher Scientific ImmunoDiagnostics Phadia GmbH, Freiburg, Germany.
  • Steller L; Assay Design, Thermo Fisher Scientific ImmunoDiagnostics Phadia GmbH, Freiburg, Germany.
  • Hauser T; Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland.
  • Manni S; Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland.
  • Gardiner DF; Immunology, CSL Behring, King of Prussia, Pennsylvania, United States of America.
  • Popik S; Immunology, CSL Behring, King of Prussia, Pennsylvania, United States of America.
  • Roth NJ; Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland.
  • Schuetz P; Department of Bioanalytical Sciences, Plasma Product Development, Research & Development, CSL Behring AG, Bern, Switzerland.
PLoS One ; 16(11): e0259731, 2021.
Article en En | MEDLINE | ID: mdl-34843493
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunoglobulinas Intravenosas / SARS-CoV-2 / COVID-19 / Modelos Biológicos / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Inmunoglobulinas Intravenosas / SARS-CoV-2 / COVID-19 / Modelos Biológicos / Anticuerpos Antivirales Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Estados Unidos